chr11-17641835-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001292063.2(OTOG):​c.8191-12C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00233 in 1,545,652 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 34 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 44 hom. )

Consequence

OTOG
NM_001292063.2 intron

Scores

2
Splicing: ADA: 0.03026
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.00

Publications

0 publications found
Variant links:
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
OTOG Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 18B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-17641835-C-A is Benign according to our data. Variant chr11-17641835-C-A is described in ClinVar as Benign. ClinVar VariationId is 226915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0125 (1900/152184) while in subpopulation AFR AF = 0.043 (1784/41502). AF 95% confidence interval is 0.0413. There are 34 homozygotes in GnomAd4. There are 903 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 34 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGNM_001292063.2 linkc.8191-12C>A intron_variant Intron 51 of 55 ENST00000399397.6 NP_001278992.1
OTOGNM_001277269.2 linkc.8227-12C>A intron_variant Intron 50 of 54 NP_001264198.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGENST00000399397.6 linkc.8191-12C>A intron_variant Intron 51 of 55 5 NM_001292063.2 ENSP00000382329.2
OTOGENST00000399391.7 linkc.8227-12C>A intron_variant Intron 50 of 54 5 ENSP00000382323.2

Frequencies

GnomAD3 genomes
AF:
0.0125
AC:
1896
AN:
152066
Hom.:
34
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0430
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00621
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00671
GnomAD2 exomes
AF:
0.00260
AC:
373
AN:
143718
AF XY:
0.00194
show subpopulations
Gnomad AFR exome
AF:
0.0423
Gnomad AMR exome
AF:
0.00313
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000133
Gnomad OTH exome
AF:
0.000959
GnomAD4 exome
AF:
0.00122
AC:
1707
AN:
1393468
Hom.:
44
Cov.:
29
AF XY:
0.00106
AC XY:
731
AN XY:
687212
show subpopulations
African (AFR)
AF:
0.0436
AC:
1375
AN:
31522
American (AMR)
AF:
0.00322
AC:
114
AN:
35452
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24860
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35718
South Asian (SAS)
AF:
0.0000509
AC:
4
AN:
78540
European-Finnish (FIN)
AF:
0.0000209
AC:
1
AN:
47798
Middle Eastern (MID)
AF:
0.00316
AC:
18
AN:
5688
European-Non Finnish (NFE)
AF:
0.0000427
AC:
46
AN:
1076090
Other (OTH)
AF:
0.00258
AC:
149
AN:
57800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
85
170
256
341
426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0125
AC:
1900
AN:
152184
Hom.:
34
Cov.:
32
AF XY:
0.0121
AC XY:
903
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0430
AC:
1784
AN:
41502
American (AMR)
AF:
0.00620
AC:
95
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67988
Other (OTH)
AF:
0.00664
AC:
14
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
94
188
282
376
470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00159
Hom.:
0
Bravo
AF:
0.0139
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Aug 23, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 22, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

8227-12C>A in intron 50 of OTOG: This variant is not expected to have clinical s ignificance because it has been identified in 5.1% (9/176) of Yoruba (Nigerian) chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi .nlm.nih.gov/projects/SNP; dbSNP rs11828989).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.7
DANN
Benign
0.63
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.030
dbscSNV1_RF
Benign
0.10
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11828989; hg19: chr11-17663382; API